Rapid clinical effectiveness of MIF-I in the treatment of major depressive illness
- 30 June 1983
- Vol. 4 (3) , 297-300
- https://doi.org/10.1016/0196-9781(83)90136-5
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depressionAmerican Journal of Psychiatry, 1978
- POTENTIATION OF LEVODOPA EFFECT BY INTRAVENOUS L-PROLYL-L-LEUCYL-GLYCINE AMIDE IN MANThe Lancet, 1975
- Melanocyte-Stimulating Hormone-Release Inhibiting Hormone as an AntidepressantArchives of General Psychiatry, 1974
- Effect of Melanocyte-Stimulating Hormone-Release Inhibiting Factor (MIF) in Parkinson’s SyndromEuropean Neurology, 1974
- Deserpidine Antagonism by a Tripeptide, L-Prolyl-L-LeucylglycinamideNeuroendocrinology, 1973
- DOPA Potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF)Life Sciences, 1971